Aclidinium: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Aclidinium. Educational only — not medical advice.

Labeled uses

TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Source: FDA labeling via NIH DailyMed (set 6f92cceb…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.